Back to Search
Start Over
B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris.
- Source :
-
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2016 Jun; Vol. 26 (6), pp. 495-501. Date of Electronic Publication: 2015 Dec 23. - Publication Year :
- 2016
-
Abstract
- Background: Methylenetetrahydrofolate dehydrogenase (MTHFD1) catalyzes three sequential reactions that metabolize derivatives of tetrahydrofolate (THF) in folate-dependent one-carbon metabolism. Impaired MTHFD1 flux has been linked to disturbed lipid metabolism and oxidative stress. However, limited information is available on its relation to the development of atherothrombotic cardiovascular disease.<br />Methods and Results: We explored the association between a MTHFD1 polymorphism (rs1076991 C > T) and acute myocardial infarction (AMI), and potential effect modifications by folic acid/B12 and/or vitamin B6 treatment in suspected stable angina pectoris patients (n = 2381) participating in the randomized Western Norway B Vitamin Intervention Trial (WENBIT). During the median follow-up of 4.9 years 204 participants (8.6%) suffered an AMI. After adjusting for established CVD risk factors, the MTHFD1 polymorphism was significantly associated with AMI (HR: 1.49; 95% CI, 1.23-1.81). A similar association was observed among patients allocated to treatment with vitamin B6 alone (HR: 1.53; 95% CI, 1.01-2.31), and an even stronger relationship was seen in patients treated with both vitamin B6 and folic acid/B12 (HR: 2.35; 95% CI, 1.55-3.57). However, no risk association between the MTHFD1 polymorphism and AMI was seen in patients treated with placebo (HR: 1.29; 95% CI, 0.86-1.93) or folic acid/B12 (1.17; 95% CI, 0.83-1.65).<br />Conclusion: A common and functional MTHFD1 polymorphism is associated with increased risk of AMI, although the risk seems to be dependent on specific B vitamin treatment. Further studies are warranted to elucidate the possible mechanisms, also in order to explore potential effect modifications by nutritional factors.<br /> (Copyright © 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. All rights reserved.)
- Subjects :
- Aged
Angina, Stable diagnosis
Angina, Stable enzymology
Angina, Stable genetics
Female
Folic Acid therapeutic use
Genetic Predisposition to Disease
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Infarction diagnosis
Myocardial Infarction enzymology
Myocardial Infarction genetics
Norway
Phenotype
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Vitamin B 6 therapeutic use
Angina, Stable drug therapy
Methylenetetrahydrofolate Dehydrogenase (NADP) genetics
Minor Histocompatibility Antigens genetics
Myocardial Infarction prevention & control
Polymorphism, Genetic
Vitamin B Complex therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1590-3729
- Volume :
- 26
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Nutrition, metabolism, and cardiovascular diseases : NMCD
- Publication Type :
- Academic Journal
- Accession number :
- 26803590
- Full Text :
- https://doi.org/10.1016/j.numecd.2015.12.009